Motley Fool Asset Management LLC Boosts Holdings in Intuitive Surgical, Inc. $ISRG

Motley Fool Asset Management LLC raised its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRGFree Report) by 28.5% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 36,908 shares of the medical equipment provider’s stock after purchasing an additional 8,176 shares during the quarter. Intuitive Surgical accounts for approximately 0.8% of Motley Fool Asset Management LLC’s investment portfolio, making the stock its 24th biggest holding. Motley Fool Asset Management LLC’s holdings in Intuitive Surgical were worth $20,903,000 as of its most recent SEC filing.

Other hedge funds also recently added to or reduced their stakes in the company. Newbridge Financial Services Group Inc. boosted its holdings in Intuitive Surgical by 300.0% in the fourth quarter. Newbridge Financial Services Group Inc. now owns 44 shares of the medical equipment provider’s stock valued at $25,000 after purchasing an additional 33 shares during the last quarter. Holos Integrated Wealth LLC acquired a new position in shares of Intuitive Surgical in the fourth quarter worth about $25,000. Olistico Wealth LLC acquired a new position in shares of Intuitive Surgical in the fourth quarter worth about $28,000. Laurel Wealth Advisors LLC acquired a new position in shares of Intuitive Surgical in the fourth quarter worth about $31,000. Finally, Turning Point Benefit Group Inc. raised its position in shares of Intuitive Surgical by 833.3% in the fourth quarter. Turning Point Benefit Group Inc. now owns 56 shares of the medical equipment provider’s stock worth $32,000 after acquiring an additional 50 shares during the period. 83.64% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In related news, Director Amy L. Ladd sold 500 shares of the company’s stock in a transaction dated Tuesday, April 28th. The shares were sold at an average price of $473.46, for a total transaction of $236,730.00. Following the completion of the transaction, the director owned 239 shares in the company, valued at $113,156.94. This represents a 67.66% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Iman Jeddi sold 5,625 shares of the company’s stock in a transaction dated Monday, June 1st. The stock was sold at an average price of $420.55, for a total transaction of $2,365,593.75. Following the transaction, the senior vice president owned 6,463 shares of the company’s stock, valued at approximately $2,718,014.65. This trade represents a 46.53% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 6,698 shares of company stock worth $2,859,708 in the last 90 days. Insiders own 0.60% of the company’s stock.

Analyst Ratings Changes

A number of research analysts have weighed in on ISRG shares. Deutsche Bank Aktiengesellschaft decreased their price objective on shares of Intuitive Surgical from $440.00 to $366.00 and set a “sell” rating for the company in a research report on Tuesday, June 2nd. Wall Street Zen downgraded shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a research report on Sunday, May 24th. The Goldman Sachs Group set a $558.00 price objective on shares of Intuitive Surgical in a research report on Wednesday, May 27th. Raymond James Financial decreased their price objective on shares of Intuitive Surgical from $615.00 to $577.00 and set an “outperform” rating for the company in a research report on Wednesday, April 22nd. Finally, Zacks Research downgraded shares of Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research report on Monday, March 30th. Nineteen research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $573.63.

Get Our Latest Stock Analysis on ISRG

Intuitive Surgical Stock Up 1.9%

ISRG opened at $426.61 on Wednesday. Intuitive Surgical, Inc. has a twelve month low of $396.68 and a twelve month high of $603.88. The company has a 50-day moving average price of $445.72 and a 200 day moving average price of $498.83. The company has a market cap of $151.09 billion, a PE ratio of 51.71, a price-to-earnings-growth ratio of 3.34 and a beta of 1.46.

Intuitive Surgical (NASDAQ:ISRGGet Free Report) last released its quarterly earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share for the quarter, topping the consensus estimate of $2.08 by $0.42. Intuitive Surgical had a net margin of 28.15% and a return on equity of 15.98%. The firm had revenue of $2.77 billion during the quarter, compared to the consensus estimate of $2.62 billion. During the same quarter in the prior year, the firm earned $1.81 EPS. The company’s revenue for the quarter was up 23.0% on a year-over-year basis. As a group, sell-side analysts expect that Intuitive Surgical, Inc. will post 8.57 earnings per share for the current year.

Trending Headlines about Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

About Intuitive Surgical

(Free Report)

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.

Featured Articles

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRGFree Report).

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.